![Aitana Peire](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aitana Peire
Director of Investments bei
The Johns Hopkins University (Investment Management)
Profil
Dr. Aitana Peire is a Director of Investments at The Johns Hopkins University and an Observer at Cercare Medical A/S.
She is on the Board of Directors at Hubro Therapeutics AS.
Dr. Peire was previously employed as an Investment Director by Canica Holding AG, an Analyst by Crédit Agricole Cheuvreux SA (Switzerland), and an Analyst by Kepler Cheuvreux SA (Switzerland).
She also served on the board at Ultimovacs ASA and EXACT Therapeutics AS.
She received her doctorate degree from the University of Groningen.
Aktive Positionen von Aitana Peire
| Unternehmen | Position | Beginn |
|---|---|---|
Cercare Medical A/S
 Cercare Medical A/S Packaged SoftwareTechnology Services Provides automated identification of viable tissue in acute stroke | Corporate Officer/Principal | - |
Hubro Therapeutics AS
 Hubro Therapeutics AS BiotechnologyHealth Technology Develops immunotherapies and neo-antigen vaccines for treatment of cancer | Direktor/Vorstandsmitglied | - |
The Johns Hopkins University (Investment Management)
 The Johns Hopkins University (Investment Management) Investment ManagersFinance Profile Unavailable. | Director of Investments | 01.01.2024 |
Ehemalige bekannte Positionen von Aitana Peire
| Unternehmen | Position | Ende |
|---|---|---|
Canica Holding AG
 Canica Holding AG Investment ManagersFinance Provides investment advice | Director of Investments | 01.01.2024 |
Ultimovacs ASA
 Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Direktor/Vorstandsmitglied | 13.12.2023 |
| EXACT THERAPEUTICS | Direktor/Vorstandsmitglied | 08.06.2022 |
Kepler Cheuvreux SA (Switzerland)
 Kepler Cheuvreux SA (Switzerland) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.11.2013 |
Crédit Agricole Cheuvreux SA (Switzerland)
 Crédit Agricole Cheuvreux SA (Switzerland) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 06.08.2013 |
Ausbildung von Aitana Peire
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crédit Agricole Cheuvreux SA (Switzerland)
Crédit Agricole Cheuvreux SA (Switzerland) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Kepler Cheuvreux SA (Switzerland)
Kepler Cheuvreux SA (Switzerland) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ultimovacs ASA
Ultimovacs ASA Pharmaceuticals: MajorHealth Technology Develops novel peptide based therapeutic cancer vaccine | Health Technology |
Cercare Medical A/S
Cercare Medical A/S Packaged SoftwareTechnology Services Provides automated identification of viable tissue in acute stroke | Technology Services |
Canica Holding AG
Canica Holding AG Investment ManagersFinance Provides investment advice | Finance |
EXACT Therapeutics AS
 EXACT Therapeutics AS BiotechnologyHealth Technology Develops technology platform for targeted drug delivery | Health Technology |
The Johns Hopkins University (Investment Management)
The Johns Hopkins University (Investment Management) Investment ManagersFinance Profile Unavailable. | Finance |
Hubro Therapeutics AS
Hubro Therapeutics AS BiotechnologyHealth Technology Develops immunotherapies and neo-antigen vaccines for treatment of cancer | Health Technology |
